Hosted on MSN25d
CHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapyIn 2023, the FDA approved two gene therapies after rigorous clinical trials that took place at CHOP and other sites. "To see what people have been working on in the laboratory for so long ...
The Children’s Hospital of Philadelphia is marking a milestone in its history with a new building dedicated to children’s ...
In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...
The 24-story building will house multiple specialties and give families access to a fitness center, entertainment hub and ...
This has driven Rivella, Thompson, and their colleagues at CHOP to remain focused on increasing treatment choices for sickle-cell disease. As well as developing in vivo gene editing, they are ...
4don MSN
Comcast chief Brian Roberts has pledged $125 million to Children's Hospital of Philadelphia to build a new tower and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results